Accelerating Oral Peptide Therapeutic Lead Selection & Development by Integrating High-Throughput Screening, Molecular Dynamics Simulations & Predictive Modelling

2:30 pm - Wednesday 2nd December 2026

  • Explore how high-throughput GI permeability and stability screening platforms accelerate lead selection and optimal drug delivery system to maximise oral bioavailability.
  • Understand the complex relationship between peptide API structure and drug delivery systems affecting oral exposure.
  • Discover how integrating high throughput screening with computational tools can advance lead selection and rapid identification of optimal drug delivery system.
  • Assessment potential of AI-ML enabled tools leveraging multidimensional data (permeability, stability, dissolution, and oral PK) to accelerate the development of peptide APIs and formulations optimised for maximal oral exposure.

Speakers:

Co-Founder & Chief Executive Officer
Vivtex Corp.